Document is current
Any future updates will be listed below
-
Authors
Zeming, Kerwin Kwek https://orcid.org/0000-0002-3088-3604
Quek, Kai Yun
Sin, Wei-Xiang
Teo, Denise Bei Lin
Cheung, Ka-Wai
Goh, Chin Ren
Kairi, Faris
Lee, Elizabeth
Lim, Francesca Lorraine Wei Inng
Seng, Michaela Su-Fern
Soh, Shui Yen
Birnbaum, Michael E. https://orcid.org/0000-0002-2281-3518
Han, Jongyoon https://orcid.org/0000-0001-7215-1439
-
Funding
Funding for this research was provided by:
National Research Foundation Singapore (SMART-CAMP)
- License Information
-
More Information
Article History
Received: 3 May 2024
Accepted: 30 April 2025
First Online: 22 May 2025
Competing interests
: M.E.B. is a founder, consultant, and equity holder of Kelonia Therapeutics and Abata Therapeutics. J.H. and K.K.Z. have filed a patent (pending) WO/2021/141539 based on the designs of the biophysical microfluidic assay. The remaining authors declare no competing interests.
